Align Technology (ALGN) Set to Post Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is anticipated to release its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect Align Technology to announce earnings of $2.77 per share and revenue of $1.00 billion for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, October 28, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating analysts’ consensus estimates of $2.62 by $0.02. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the firm posted $2.49 earnings per share. On average, analysts expect Align Technology to post $9.27 EPS for the current fiscal year and $10.34 EPS for the next fiscal year.

Align Technology Price Performance

Shares of ALGN opened at $154.51 on Monday. The company has a market capitalization of $11.07 billion, a PE ratio of 26.87, a price-to-earnings-growth ratio of 1.66 and a beta of 1.67. Align Technology has a one year low of $130.23 and a one year high of $200.43. The company’s fifty day moving average price is $151.62 and its 200 day moving average price is $166.51.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on ALGN shares. Piper Sandler decreased their price target on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating for the company in a report on Wednesday. Leerink Partners dropped their price objective on Align Technology from $235.00 to $215.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 14th. UBS Group reissued a “neutral” rating and set a $189.00 price objective on shares of Align Technology in a research report on Thursday, July 23rd. Robert W. Baird reissued a “neutral” rating and set a $162.00 price objective (down from $218.00) on shares of Align Technology in a research report on Thursday, October 15th. Finally, Zacks Research downgraded Align Technology from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $190.93.

Align Technology Company Profile

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.